Acerus Announces Executive Leadership Changes- progress! Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”)
(TSX:ASP) today announced that Robert M. Motz will join the Company as
Chief Financial Officer, effective today, and will become a member of
Acerus’ Senior Leadership Team. The Company also announced that Ken
Yoon, the Company’s current Chief Financial Officer, has decided to
leave Acerus at the end of October to pursue other opportunities.
“I am pleased to announce that Robert Motz is joining our company,” said
Ed Gudaitis, President and CEO of Acerus. “Bob has an outstanding track
record of raising capital, managing finance and operations, working
internationally and implementing mergers and acquisitions, which we
believe will be critical to our future success.”
Mr. Motz brings more than 30 years of finance and operations experience
to Acerus. He joins the company from Hydrogenics Corporation, a
dual-listed (NASDAQ and TSX) clean technology leader. While at
Hydrogenics, as Chief Financial Officer, he led investor relations,
raised more than $75 million in capital, managed overseas investments
and upgraded enterprise resource planning systems globally. Prior to
joining Hydrogenics, Mr. Motz served as President and CEO and Senior
Vice President and CFO of Aeroquest International Limited. While at
Aeroquest, he led the organization through numerous acquisition and
restructuring transactions, as well as many other strategic and
operational initiatives across Canada, the United States and Australia.
Mr. Motz received his bachelor’s degree in commerce from the University
of Toronto and has a CPA, CA designation.
Mr. Yoon is expected to work with Mr. Motz and other leaders to
transition his duties.
“I am grateful to Ken for his work to strengthen Acerus’ balance sheet
and cash position, ensuring that we are well-positioned for future
growth,” said Mr. Gudaitis. “He has been instrumental in our recent
financings and operational results and we wish him the very best in the
next phase of his career.”